Bruce & Co., Inc.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 14, 2025), Bruce & Co., Inc. reported 41 stock positions worth $310.5 million. Its top holding was U-Haul Holding Co.-Non Voting (UHAL.B) at 8.6% of the portfolio, followed by Abbvie (ABBV, 8.6%) and Allstate (ALL, 8.4%). Compared with Q4 2024, it opened 2 new positions, added to 2 and reduced 9. The biggest buy was Aercap (AER, shares +22%) and the biggest sale U-Haul Holding Co.-Non Voting (UHAL.B, shares −3%).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001358331
- Portfolio Value
- $310.5M (Q1 2025)
- SEC Filing
- 0001104659-25-048350 ↗ filed May 14, 2025
Holdings Value
Holdings 41 stocks · $310.5M
| UHAL.B U-Haul Holding Co.-Non Voting | 8.61% | 452,000 | $26.7M | Reduce -3.2% |
| ABBV Abbvie Inc. | 8.60% | 127,500 | $26.7M | Reduce -7.3% |
| ALL Allstate Corp. | 8.37% | 125,500 | $26.0M | Reduce -3.8% |
| Nextera Energy filed as FPL GROUP INC | 7.19% | 315,000 | $22.3M | No change |
| DUK Duke Energy Corp. | 6.91% | 175,816 | $21.4M | Reduce -10.2% |
| T AT&T Inc. | 6.13% | 673,000 | $19.0M | Reduce -12.9% |
| AER Aercap Holdings NV | 6.04% | 183,500 | $18.7M | Add +22.3% |
| MRK Merck & Co Inc | 5.86% | 202,800 | $18.2M | Reduce -4.7% |
| ABT Abbott Laboratories | 5.72% | 133,800 | $17.7M | Reduce -9.8% |
| CMS CMS Energy Corp. | 5.47% | 226,000 | $17.0M | Reduce -21.0% |
| XEL Xcel Energy Inc. | 4.43% | 194,500 | $13.8M | No change |
| IIIN Insteel Industries Inc. | 2.91% | 343,423 | $9.0M | No change |
| AAPL Apple Inc. | 2.78% | 38,900 | $8.6M | No change |
| AVA Avista Corp. | 2.72% | 201,500 | $8.4M | No change |
| PFE Pfizer Inc. | 2.22% | 271,900 | $6.9M | No change |
| BG Bunge Global SA | 1.97% | 80,000 | $6.1M | No change |
| UHAL U-Haul Holding Co. | 1.56% | 73,900 | $4.8M | No change |
| NEM Newmont Corp. | 1.55% | 100,000 | $4.8M | No change |
| ADM Archer-Daniels-Midland Co. | 1.55% | 100,000 | $4.8M | No change |
| DAR Darling Ingredients Inc. | 1.42% | 141,000 | $4.4M | No change |
| RLI Rli Corp. | 1.06% | 40,800 | $3.3M | No change |
| VICR Vicor Corp. | 1.05% | 70,000 | $3.3M | No change |
| CC The Chemours Co. | 0.87% | 200,000 | $2.7M | New |
| SUPN Supernus Pharmaceuticals Inc. | 0.87% | 82,105 | $2.7M | No change |
| LLY Eli Lilly & Co. | 0.53% | 2,000 | $1.7M | No change |
| SIRI Sirius XM Holdings Inc. | 0.40% | 55,784 | $1.3M | No change |
| VALEANT PHARMACEUTICALS INTL filed as Bausch Health | 0.36% | 171,000 | $1.1M | No change |
| FOCL Edap TMS SA -ADR | 0.35% | 553,652 | $1.1M | No change |
| VG Venture Global Inc. Class A | 0.33% | 100,000 | $1.0M | New |
| MNKD Mannkind Corp. | 0.32% | 195,073 | $981K | No change |
| KOD Kodiak Sciences Inc. | 0.29% | 323,000 | $908K | No change |
| ASH Ashland LLC | 0.29% | 15,000 | $889K | No change |
| PSNL Personalis Inc. | 0.29% | 253,000 | $888K | No change |
| LVTX Lava Therapeutics NV | 0.21% | 521,874 | $663K | Reduce -32.4% |
| VTRS Viatris Inc. | 0.16% | 58,279 | $508K | No change |
| OGN Organon & Co. | 0.15% | 31,200 | $465K | No change |
| FATE Fate Therapeutics Inc. | 0.14% | 550,000 | $435K | Add +57.1% |
| WEC WEC Energy Group Inc. | 0.12% | 3,945 | $371K | No change |
| MASS 908 Devices Inc. | 0.10% | 68,286 | $306K | No change |
| CRBU Caribou Biosciences Inc. | 0.07% | 250,000 | $228K | No change |
| IGMS Igm Biosciences Inc. | 0.04% | 100,000 | $115K | No change |
Other holdings (1): bonds, preferreds, convertibles and warrants · $1.3M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | 3,292,574 | $1.3M | No change |
Total filed on the 13F, all lines: $311.8M.
Portfolio Sells Q4 2024 → Q1 2025
| UHAL.B U-Haul Holding Co.-Non Voting | Reduce -3.2% | 8.61% | −1.04 |
| MRK Merck & Co Inc | Reduce -4.7% | 5.86% | −0.97 |
| CMS CMS Energy Corp. | Reduce -21.0% | 5.47% | −0.68 |
| LVTX Lava Therapeutics NV | Reduce -32.4% | 0.21% | −0.02 |
| DUK Duke Energy Corp. | Reduce -10.2% | 6.91% | +0.10 |
| ALL Allstate Corp. | Reduce -3.8% | 8.37% | +0.25 |
| ABT Abbott Laboratories | Reduce -9.8% | 5.72% | +0.30 |
| T AT&T Inc. | Reduce -12.9% | 6.13% | +0.45 |
| ABBV Abbvie Inc. | Reduce -7.3% | 8.60% | +0.72 |
Portfolio Buys Q4 2024 → Q1 2025
Notes & Other Activity Q4 2024 → Q1 2025
| Acorda Theraputics | Cv 6.0% · principal | Sold out | 5,000,000 | $200Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 41 | $369.5M | ABBV, ALL, AER, Nextera Energy, MRK |
| Q1 2026 | 41 | $349.7M | Nextera Energy, ABBV, ALL, AER, MRK |
| Q4 2025 | 39 | $322.5M | ABBV, AER, ALL, Nextera Energy, UHAL.B |
| Q3 2025 | 39 | $322.9M | ABBV, ALL, Nextera Energy, UHAL.B, AER |
| Q2 2025 | 40 | $307.8M | ALL, UHAL.B, ABBV, Nextera Energy, AER |
| Q1 2025 | 41 | $310.5M | UHAL.B, ABBV, ALL, Nextera Energy, DUK |
| Q4 2024 | 39 | $309.9M | UHAL.B, ALL, ABBV, Nextera Energy, MRK |
| Q3 2024 | 39 | $342.1M | UHAL.B, ABBV, Nextera Energy, ALL, MRK |
| Q2 2024 | 38 | $299.2M | UHAL.B, MRK, ABBV, Nextera Energy, ALL |
| Q1 2024 | 37 | $297.1M | UHAL.B, MRK, ABBV, ALL, DUK |